Prevalence of Liver Function Test Abnormality and Associated Factors in Type 2 Diabetes Mellitus: A Comparative Cross-Sectional Study

Overview

Journal EJIFCC

Specialty Biochemistry

Date 2019 Nov 8

PMID 31695587

Citations 6

Authors

Getnet Teshome

Sintayehu Ambachew

Alebachew Fasil

Molla Abebe

Affiliations

Soon will be listed here.

Abstract

Background: Determining liver biomarkers can help to screen and facilitate early management of potential liver diseases. However, such studies are scarce in the present study area. Therefore, our study planned to assess the prevalence of liver function test abnormality and associated factors among Type 2 Diabetes Mellitus (T2DM) patients.

Methods: A comparative cross-sectional study was conducted at the University of Gondar Comprehensive Specialized Hospital from January 1, 2018 to May 20, 2018 among 159 T2DM patients and 159 nondiabetic controls. Clinical, lifestyle, anthropometric data and 5 ml of blood were collected from all study subjects. Liver function tests (LFTs), lipid profiles and fasting blood sugar were determined. Systematic random sampling technique was used to select the study subjects. Binary logistic regression and bivariate correlation was used to assess association of factors with outcomes and p value of ≤0.05 was considered as significant.

Results: Overall, 53 (33.3%) of T2DM had one or more liver test abnormality above the upper limit of the normal (ULN) reference range. Alanine aminotransferase was the most frequently raised liver enzyme in T2DM (n=37, 23.3%). The mean value of LFTs was significantly different between T2DM and the control group. Alcohol drink, sex and age were found to be a significant factor for impairment of LFTs.

Conclusion: The prevalence of abnormal LFTs was higher in T2DM patients than nondiabetic control group. Hence, we recommended the utilization of LFTs to monitor liver conditions in T2DM patients.

Citing Articles

Evaluation of Vinca Rosea's Protective Effects on Hepatic Function in Streptozotocin-Induced Diabetic Wistar Albino Rats.

Mallikarjuna Rao B, Vedavijaya T, Ramani Y, Chowdhury B Cureus. 2024; 16(11):e74166.

PMID: 39712809 PMC: 11662991. DOI: 10.7759/cureus.74166.

Assessment of abnormal liver function tests and associated factors among COVID-19-infected patients in Addis Ababa, Ethiopia, 2022: a facility-based comparative cross-sectional study.

Mekuanint A, Ambachew S, Worede A, Asrie F, Sinishaw M, Gelaw Y BMJ Open. 2024; 14(9):e076647.

PMID: 39260868 PMC: 11409313. DOI: 10.1136/bmjopen-2023-076647.

The relationship between the ratio of gamma-glutamyltransferase to high-density lipoprotein cholesterol and the risk of diabetes mellitus using publicly available data: a secondary analysis based on a longitudinal study in Japan.

Zhao Y, Xin X, Luo X Lipids Health Dis. 2023; 22(1):7.

PMID: 36650520 PMC: 9843936. DOI: 10.1186/s12944-023-01772-9.

Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults.

Alam S, Raghav A, Reyaz A, Ahsan A, Ahirwar A, Jain V Metabol Open. 2021; 12:100130.

PMID: 34622192 PMC: 8479470. DOI: 10.1016/j.metop.2021.100130.

Evaluation of antidiabetic and hypolipidemic activity of Linn. leaves in alloxan-induced diabetic rats.

Ansari M, Saeedan A, Bajaj S, Singh L 3 Biotech. 2021; 11(4):170.

PMID: 33927962 PMC: 7969671. DOI: 10.1007/s13205-021-02728-5.

References

Hanley A, Williams K, Festa A, Wagenknecht L, DAgostino Jr R, Haffner S . Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes. 2005; 54(11):3140-7. DOI: 10.2337/diabetes.54.11.3140. View

Belkacemi L, Belalia M . Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: Wilaya of Mostaganem. Diabetes Metab Syndr. 2015; 10(1 Suppl 1):S147-50. DOI: 10.1016/j.dsx.2015.10.013. View

Lee K, Mitchell A, Shibamoto T . Antioxidative activities of aroma extracts isolated from natural plants. Biofactors. 2001; 13(1-4):173-8. DOI: 10.1002/biof.5520130128. View

Fracanzani A, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E . Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008; 48(3):792-8. DOI: 10.1002/hep.22429. View

Imam K . Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus. Adv Exp Med Biol. 2013; 771:340-55. DOI: 10.1007/978-1-4614-5441-0_25. View

Kavey R, Daniels S, Lauer R, Atkins D, Hayman L, Taubert K . American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003; 107(11):1562-6. DOI: 10.1161/01.cir.0000061521.15730.6e. View

Siest G, Schiele F, Galteau M, Panek E, Steinmetz J, Fagnani F . Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem. 1975; 21(8):1077-87. View

Casiglia E, Spolaore P, Ginocchio G, Ambrosio G . Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol. 1993; 9(3):293-7. DOI: 10.1007/BF00146266. View

Erbey J, SILBERMAN C, Lydick E . Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med. 2000; 109(7):588-90. DOI: 10.1016/s0002-9343(00)00602-1. View

10.

Saligram S, Williams E, Masding M . Raised liver enzymes in newly diagnosed Type 2 diabetes are associated with weight and lipids, but not glycaemic control. Indian J Endocrinol Metab. 2012; 16(6):1012-4. PMC: 3510928. DOI: 10.4103/2230-8210.103027. View

11.

Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A . Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol. 2008; 22(10):811-6. PMC: 2661299. DOI: 10.1155/2008/810961. View

12.

Salmela P, Sotaniemi E, Niemi M, Maentausta O . Liver function tests in diabetic patients. Diabetes Care. 1984; 7(3):248-54. DOI: 10.2337/diacare.7.3.248. View

13.

Daly A, Ballestri S, Carulli L, Loria P, Day C . Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2011; 5(2):253-63. DOI: 10.1586/egh.11.18. View

14.

Ogurtsova K, da Rocha Fernandes J, Huang Y, Linnenkamp U, Guariguata L, Cho N . IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40-50. DOI: 10.1016/j.diabres.2017.03.024. View

15.

Arias F . Hepatic fibrinogen deposits in pre-eclampsia. Immunofluorescent evidence. N Engl J Med. 1976; 295(11):578-82. DOI: 10.1056/NEJM197609092951102. View

16.

Hosseinpour-Niazi S, Mirmiran P, Hosseini-Esfahani F, Azizi F . Is the metabolic syndrome inversely associates with butter, non-hydrogenated- and hydrogenated-vegetable oils consumption: Tehran lipid and glucose study. Diabetes Res Clin Pract. 2015; 112:20-29. DOI: 10.1016/j.diabres.2015.11.008. View

17.

Morling J, Strachan M, Hayes P, Butcher I, Frier B, Reynolds R . Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetes. Diabet Med. 2011; 29(4):488-91. DOI: 10.1111/j.1464-5491.2011.03492.x. View

18.

Cavin C, Mace K, Offord E, Schilter B . Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells. Food Chem Toxicol. 2001; 39(6):549-56. DOI: 10.1016/s0278-6915(00)00168-x. View

19.

Feng R, Lu Y, Bowman L, Qian Y, Castranova V, Ding M . Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem. 2005; 280(30):27888-95. DOI: 10.1074/jbc.M503347200. View

20.

de Onis M, Habicht J . Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996; 64(4):650-8. DOI: 10.1093/ajcn/64.4.650. View